METAPNEUMOVIRUS BRONCHIOLITIS

This adverse event was reported 11 times

These drugs are most commonly taken by patients reporting METAPNEUMOVIRUS BRONCHIOLITIS:

# Drug Count
0 CISPLATIN 4
1 DOXORUBICIN 4
2 FLUOROURACIL 4
3 FLUOROURACIL CREAM, 0.5% 4
4 NIRSEVIMAB 3
5 ACYCLOVIR 1
6 ALBUTEROL 1
7 ALBUTEROL SULFATE 1
8 AMLODIPINE 1
9 ANTACID 1
See all common drugs associated with METAPNEUMOVIRUS BRONCHIOLITIS

METAPNEUMOVIRUS BRONCHIOLITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIRSEVIMAB 3 0.0017
1 DEFLAZACORT 1 0.0004
2 DRONABINOL 1 0.0001
3 AXICABTAGENE CILOLEUCEL 1 0.0001
4 FLUOROURACIL CREAM, 0.5% 4 0.0001
5 FLUOROURACIL 4 0.0001
6 CISPLATIN 4 0.0001
7 DOXORUBICIN 4 0.0000
8 DOXORUBICIN HYDROCHLORIDE 1 0.0000
9 LOPERAMIDE HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with METAPNEUMOVIRUS BRONCHIOLITIS